QIAGEN Announces Supply Agreement With Roche Molecular Systems
Advertisement
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. announced that they have entered into a manufacturing and supply agreement with Roche Molecular Systems, a unit of Roche Diagnostics Basel, Switzerland, who will market QIAGEN's media sample preparation kits under their AmpliLute trademark.
This customized kit will incorporate a specific version of QIAGEN's well-established QIAamp(R) technology to purify DNA from specimens stored in liquid cytology media. QIAGEN's proprietary nucleic acid sample preparation and handling technologies provide high reliability and efficiency in both DNA and RNA separation and purification for molecular diagnostics applications.